Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551

Psychopharmacology

Volumn 175, Issue 1, 2004, Pages 114-123

  Kosowski, Alexander R ^a   Cebers, Gvido ^a   Cebere, Aleta ^a   Swanhagen, Ann Charlott ^a   Liljequist, Sture ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Affinity; Cerebellar granule cells; Glutamate receptor subtype selectivity; Locomotor activity; Microdialysis; NBQX; Systemic administration

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; [[3,4 DIHYDRO 7 MORPHOLINO 2,3 DIOXO 6 (TRIFLUOROMETHYL) 1(2H) QUINOXALINYL]METHYL]PHOSPHONIC ACID; AMPA RECEPTOR; DOPAMINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CELL CULTURE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; DRUG INHIBITION; LOCOMOTION; MALE; MICRODIALYSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; DOPAMINE; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NICOTINE; NUCLEUS ACCUMBENS; PHOSPHONIC ACIDS; QUINOXALINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; TIME FACTORS;

EID: 4544224164     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1797-7     Document Type: Article

References (60)

1. Benwell MW, Balfour DJ (1992) The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105:849-856
2. Benwell MW, Balfour DJ, Birrel CE (1993) The influence of tetrodotoxin and calcium on the stimulation of mesolimbic dopamine activity evoked by systemic nicotine. Psychopharmacology 112:467-471
3. Breese CR, Logel J, Adams C, Leonard SS (1996) Regional gene expression of the glutamate receptor subtypes GluR1, GluR2, and GluR3 in human postmortem brain. J Mol Neurosci 7:277-289
4. Cebere A, Liljequist S (2003) Ethanol differentially inhibits homoquinolinic acid- and NMDA-induced neurotoxicity in primary cultures of cerebellar granule cells. Neurochem Res 28:1193-1199
5. Cebers G, Cebere A, Zharkovsky A, Liljequist S (1996) Glycine does not reverse the inhibitory actions of ethanol on NMDA receptor functions in cerebellar granule cells. Naunyn Schmiedeberg's Arch Pharmacol 354:736-745
6. Cebers G, Zhivotovsky B, Ankarcrona M, Liljequist S (1997) AMPA neurotoxicity in cultured cerebellar granule neurons: mode of cell death. Brain Res Bull 43:393-403
7. 2+ fluxes and neurotoxicity in rat cerebellar granule cells. Brain Res 779:194-204
8. Corrigall WA, Franklin KB, Coen KM, Clarke PB (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107:285-289
9. 3H]nitro-7-sulphamoylbenzo[f]- quinoxaline-2,3-dione to rat brain. J Neurochem 67:2609-2612
10. Di Chiara G, Imperato A (1986) Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats. Ann N Y Acad Sci 473:367-381
11. Ferrari R, Le Nowere N, Picciotto MR, Changeux JP, Zoli M (2002) Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections. Eur J Neurosci 15:1810-1818
12. Fu Y, Malta SG, Gao W, Brower VG, Sharp BM (2000) Systemic nicotine stimulates dopamine release in nucleus accumbens: reevaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area. J Pharmacol Exp Ther 294:458-465
13. Grillner P, Svensson TH (2000) Nicotine-induced excitation of midbrain dopamine neurons in vitro involves ionotropic glutamate receptor activation. Synapse 38:1-9
14. 3H]GABA release from cultured cortical neurons via an inhibitory action at the strychnine-insensitive glycine site. Brain Res 489:85-89
15. Hernandez L, Lee F, Hoebel BG (1987) Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin. Brain Res Bull 19 23-28
16. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280-287
17. Hyytia P, Backstrom P, Liljequist S (1999) Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats. Eur J Pharmacol 378:9-16
18. Imperato A, Di Chiara G (1986) Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239:219-228
19. Imperato A, Mulas A, Di Chiara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338
20. Jackson A, Mead AN, Stephens DN (2000) Behavioural effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse. Pharmacol Ther 88:59-76
21. Karcz-Kubicha M, Liljequist S (1995) Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test. Eur J Pharmacol 279:171-177
22. Kessler M, Baudry M, Lynch G (1989) Quinoxaline derivatives are high-affinity antagonists of the NMDA receptor-associated glycine sites. Brain Res 489:377-382
23. Kessler M, Mutneja MS, Rogers G, Lynch G (1998) Regional preferences of AMPA receptor modulators determined through agonist binding autoradiography. Brain Res 783: 121-126
24. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723
25. Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302
26. Lester RA, Quarum ML, Parker JD, Weber E, Jahr CE (1989) Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site. Mol Pharmacol 35:565-570
27. Liu Y, Peterson DA, Kimura H, Schubert D (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69:581-593
28. 2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons. Biochem Pharmacol 50:1761-1774
29. Loftis JM, Janowsky A (2003) The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 97:55-85
30. Marcus MM, Mathe JM, Nomikos GG, Svensson TH (2001) Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens. Neuropharmacology 40:482-490
31. Mares P, Mikulecka A, Pometlova M (1997) Anticonvulsant action of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline in immature rats: comparison with the effects on motor performance. J Pharmacol Exp Ther 281:1120-1126
32. Martin LJ, Blackstone CD, Levey AI, Huganir RL, Price DL (1993) AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53:327-358
33. McGehee DA, Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521-546
34. Mead AN, Stephens DN (1999) CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors. J Pharmacol Exp Ther 290:9-15
35. Menniti F, Chenard B, Collins M, Ducat M, Shalaby I, White F (1997) CP-101,606, a potent neuroprotectant selective for forebrain neurons. Eur J Pharmacol 331:117-126
36. Mifsud JD, Hernandez L, and Hoeberl BG (1989) Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 478:365-367
37. 3H] AMPA binding sites in rat brain as determined by quantitative autoradiography. Brain Res 324:160-164
38. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65:55-63
39. 3H] alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid binding sites. J Neurochem 54:686-695
40. Nisell M, Nomikos GG and Svensson TH (1994) Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of rat differentially affects accumbal dopamine release. Pharmacol Toxicol 75:348-352
41. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, New York
42. Picciotto MR (1998) Common aspects of the action of nicotine and other drugs of abuse. Drug Alcohol Depend 51:165-172
43. Pellegrini-Giampietro DE, Galli A, Alesiani M, Cherici G, Moroni F (1989) Quinoxalines interact with the glycine recognition site of NMDA receptors: studies in guinea-pig myenteric plexus and in rat cortical membranes. Br J Pharmacol 98:1281-1286
44. Porter RH, Greenamyre JT (1994) Regional variations in the pharmacology of AMPA receptors as revealed by receptor autoradiography. Brain Res 664:202-206
45. Reid MS, Fox L, Ho LB, Berger SP (2000) Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization. Synapse 35:129-136
46. Romano C, Goldstein A (1980) Stereospecific nicotine receptors on rat brain membranes. Science 210:647-650
47. Sakai K, Akiyama K, Kashihara K, Tsuchida K, Ujike H, Kuroda S, Shohmori T (1997) AMPA receptors modulate dopamine release in the striatum, as measured by brain microdialysis. Neurochem Int 30:329-336
48. Schilstrom B, Nomikos GG, Nisell M, Hertel P, Svensson TH (1998) N-Methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 82:781-789
49. Schoepp DD, Lodge D, Bleakman D, Leander JD, Tizzano JP, Wright RA, Palmer AJ, Salhoff CR, Ornstein PL (1995) In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid. Neuropharmacology 34:1159-1168
50. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247:571-574
51. Stephens DN, Brown G (1999) Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466. Alcohol Clin Exp Res 23:1914-1920
52. Sziraki I, Sershen H, Hashim A, Lajtha A (2002) Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem Res 27:253-261
53. Toth E, Vizi ES, Lajtha A (1993) Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacology 32:827-832
54. Turski L, Jaconsen P, Honoré T, Stephens DN (1992) Relief of experimental plasticity and anxiolytic/anticonvulscant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate antagonist, 2,3-dihydro-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. J Pharmacol Exp Ther 260:742-747
55. Turski L, Huth A, Sheardown M, McDonald F, Neuhaus R, Schneider HH, Dirnagl U, Wiegand F, Jacobsen P, Ottow E (1998) ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci USA 95:10960-10965
56. Turski L, Schneider HH, Neuhaus R, McDonald F, Jones GH, Lofberg B, Schweinfurth H, Huth A, Kruger M, Ottow E (2000) Phosphonate quinoxalinedione AMPA antagonists. Restor Neurol Neurosci 17:45-59
57. Vanover KE (1998) Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice. Psychopharmacology 136:123-131
58. Wang T, French ED (1993) Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Synapse 13:270-277
59. Williams K (2001) Ifenprodil, a novel NMDA receptor antagonist: site and mechanism of action. Curr Drug Targets 2:285-298
60. Wise RA, Bozarth MA (1987). A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492